On the other hand, HER3/HER4-specific ligands (heregulins/neuregulins) have been found to induce cell differentiation [48,49] and even apoptosis [48,49,50,51,52], thus eliciting tumor-suppressive effects. This evidence concerns the gene ERBB3 and neoplasm.